Published in Stem Cells Dev on September 20, 2012
iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease. Cell Rep (2014) 1.08
Genetic strategies to investigate neuronal circuit properties using stem cell-derived neurons. Front Cell Neurosci (2012) 0.82
Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons. Stem Cell Reports (2014) 0.81
CASMI TSCC launch event, Paris, France, July 2013: an assessment of the key barriers to the commercialization and clinical adoption of pluripotent stem cell therapies. Rejuvenation Res (2014) 0.77
Self-assembling peptide nanofiber scaffolds enhance dopaminergic differentiation of mouse pluripotent stem cells in 3-dimensional culture. PLoS One (2013) 0.76
Efficient derivation of dopaminergic neurons from SOX1(-) floor plate cells under defined culture conditions. J Biomed Sci (2016) 0.75
Characterization of neural stemness status through the neurogenesis process for bone marrow mesenchymal stem cells. Stem Cells Cloning (2016) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
'Green mice' as a source of ubiquitous green cells. FEBS Lett (1997) 17.06
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell (1990) 10.99
Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature (2002) 6.51
Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron (2000) 6.33
Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol (2000) 6.21
Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature (1988) 6.12
Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech Dev (1998) 5.21
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A (2002) 4.20
Purmorphamine activates the Hedgehog pathway by targeting Smoothened. Nat Chem Biol (2005) 3.49
Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol (2003) 3.43
Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells (2005) 3.38
FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell (1998) 3.33
Identification of intrinsic determinants of midbrain dopamine neurons. Cell (2006) 3.31
Interpretation of the sonic hedgehog morphogen gradient by a temporal adaptation mechanism. Nature (2007) 2.97
The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol (2007) 2.54
How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci (2007) 2.33
A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat Neurosci (2000) 2.20
Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc Natl Acad Sci U S A (2003) 2.14
Neural plate patterning: upstream and downstream of the isthmic organizer. Nat Rev Neurosci (2001) 2.06
Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis. Nat Neurosci (2009) 2.03
Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells. Development (2007) 2.01
Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J Neurosci (2001) 1.99
Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A (2008) 1.97
Gene function in early mouse embryonic stem cell differentiation. BMC Genomics (2007) 1.96
Otx2 regulates subtype specification and neurogenesis in the midbrain. J Neurosci (2005) 1.59
Otx2 regulates the extent, identity and fate of neuronal progenitor domains in the ventral midbrain. Development (2004) 1.59
Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci U S A (2009) 1.57
Otx2, Gbx2 and Fgf8 interact to position and maintain a mid-hindbrain organizer. Curr Opin Cell Biol (2000) 1.53
Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem Cell (2009) 1.51
Distinct Sonic Hedgehog signaling dynamics specify floor plate and ventral neuronal progenitors in the vertebrate neural tube. Genes Dev (2010) 1.51
Genetic networks controlling the development of midbrain dopaminergic neurons. J Physiol (2006) 1.41
Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development (2004) 1.37
Spatiotemporally separable Shh domains in the midbrain define distinct dopaminergic progenitor pools. Proc Natl Acad Sci U S A (2009) 1.37
Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development. Dev Biol (2009) 1.36
Midbrain dopamine neuron differentiation: factors and fates. Dev Biol (2007) 1.29
Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon. Development (2008) 1.28
Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc Natl Acad Sci U S A (2006) 1.26
Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons. J Neurosci (2010) 1.26
Purified Wnt-5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation. J Neurochem (2005) 1.24
Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells. Stem Cells (2005) 1.22
Establishment of a new embryonic stem cell line derived from C57BL/6 mouse expressing EGFP ubiquitously. Genesis (2005) 1.22
Lmx1a and Lmx1b cooperate with Foxa2 to coordinate the specification of dopaminergic neurons and control of floor plate cell differentiation in the developing mesencephalon. Dev Biol (2009) 1.21
Fibroblast growth factor receptors cooperate to regulate neural progenitor properties in the developing midbrain and hindbrain. J Neurosci (2007) 1.18
ES cell-derived renewable and functional midbrain dopaminergic progenitors. Proc Natl Acad Sci U S A (2011) 1.17
Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells (2006) 1.16
Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev (2010) 1.15
Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells. Hum Gene Ther (2011) 1.15
Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein. Nat Med (1995) 1.14
Regulation of ventral midbrain patterning by Hedgehog signaling. Development (2007) 1.14
Nkx6-1 controls the identity and fate of red nucleus and oculomotor neurons in the mouse midbrain. Development (2009) 1.11
Lmx1a and lmx1b function cooperatively to regulate proliferation, specification, and differentiation of midbrain dopaminergic progenitors. J Neurosci (2011) 1.08
Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells. Development (2011) 1.08
Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival. Stem Cells (2010) 1.06
Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev Biol (1989) 1.02
Midbrain dopaminergic neuron fate specification: Of mice and embryonic stem cells. Mol Brain (2008) 0.96
Purmorphamine increases DARPP-32 differentiation in human striatal neural stem cells through the Hedgehog pathway. Stem Cells Dev (2011) 0.96
Isthmus organizer for midbrain and hindbrain development. Brain Res Brain Res Rev (2005) 0.96
Signals from the ventral midline and isthmus regulate the development of Brn3.0-expressing neurons in the midbrain. Mech Dev (2001) 0.91
Dynamic expression patterns of Nkx6.1 and Nkx6.2 in the developing mes-diencephalic basal plate. Dev Dyn (2010) 0.88
Will stem cell biology generate new therapies for Parkinson's disease? Neuron (2008) 0.88
The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J Neurosci (1991) 0.86
Convergent Wnt and FGF signaling at the gastrula stage induce the formation of the isthmic organizer. Mech Dev (2006) 0.82
Early appearance of tyrosine hydroxylase immunoreactive cells in the mesencephalon of mouse embryos. Int J Dev Neurosci (1990) 0.80
Pharmacological modulation of the Hedgehog pathway differentially affects dorsal/ventral patterning in mouse and human embryonic stem cell models of telencephalic development. Stem Cells Dev (2012) 0.80
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation (2004) 2.08
The diagnosis of Parkinson's disease. Lancet Neurol (2006) 1.97
The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. J Neurosci (2005) 1.86
Reversal of cocaine-conditioned place preference and mesocorticolimbic Zif268 expression by social interaction in rats. Addict Biol (2011) 1.36
Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons. J Neurosci (2002) 1.24
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). Mov Disord (2010) 1.18
Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol (2003) 1.15
Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord (2004) 1.14
Mutant COQ2 in multiple-system atrophy. N Engl J Med (2014) 1.13
The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection. J Virol (2007) 1.03
Preventive role of social interaction for cocaine conditioned place preference: correlation with FosB/DeltaFosB and pCREB expression in rat mesocorticolimbic areas. Front Behav Neurosci (2012) 1.01
Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA. Mol Cell Neurosci (2004) 0.94
From cell death to neuronal regeneration, effects of the p75 neurotrophin receptor depend on interactions with partner subunits. Sci STKE (2004) 0.93
Identification of differentially expressed non-coding RNAs in embryonic stem cell neural differentiation. Nucleic Acids Res (2012) 0.92
Development of neurotransmitter phenotypes in sympathetic neurons. Auton Neurosci (2009) 0.90
Brain regions associated with the acquisition of conditioned place preference for cocaine vs. social interaction. Front Behav Neurosci (2012) 0.90
Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT. Neuroimage (2002) 0.90
Opposing functions of GDNF and NGF in the development of cholinergic and noradrenergic sympathetic neurons. Mol Cell Neurosci (2002) 0.89
The sympathetic neurotransmitter switch depends on the nuclear matrix protein Satb2. J Neurosci (2010) 0.89
Induced pluripotent stem cells from friedreich ataxia patients fail to upregulate frataxin during in vitro differentiation to peripheral sensory neurons. Stem Cells Dev (2013) 0.86
p38α and p38β mitogen-activated protein kinases determine cholinergic transdifferentiation of sympathetic neurons. J Neurosci (2011) 0.84
Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study. Mov Disord (2007) 0.84
Milestones of directed differentiation of mouse and human embryonic stem cells into telencephalic neurons based on neural development in vivo. Stem Cells Dev (2011) 0.84
Striatal transplantation in a rodent model of multiple system atrophy: effects on L-Dopa response. J Neurosci Res (2009) 0.83
Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection. Hippocampus (2010) 0.83
Regulation, cellular localization, and function of the p75 neurotrophin receptor (p75NTR) during the regeneration of facial motoneurons. Mol Cell Neurosci (2003) 0.81
Acetylcholine, drug reward and substance use disorder treatment: intra- and interindividual striatal and accumbal neuron ensemble heterogeneity may explain apparent discrepant findings. Pharmacology (2012) 0.81
Neurotransmitter phenotype-specific expression changes in developing sympathetic neurons. Mol Cell Neurosci (2007) 0.81
Antigen recognition properties of a Vgamma1.3Vdelta2-T-cell receptor from a rare variant of polymyositis. J Neuroimmunol (2004) 0.80
Optimal noise-aided signal transmission through populations of neurons. Phys Rev E Stat Nonlin Soft Matter Phys (2003) 0.80
Neurotrophic factors acutely alter the sorting of the vesicular acetyl choline transporter and the vesicular monoamine transporter 2 in bimodal sympathetic neurons. Mol Cell Neurosci (2006) 0.80
Pharmacological modulation of the Hedgehog pathway differentially affects dorsal/ventral patterning in mouse and human embryonic stem cell models of telencephalic development. Stem Cells Dev (2012) 0.80
Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy). Acta Neuropathol (2003) 0.79
Co-stimulatory and adhesion molecules of dendritic cells in rheumatoid arthritis. J Cell Mol Med (2002) 0.79
Increased daytime sleepiness in Parkinson's disease: a questionnaire survey. Mov Disord (2003) 0.79
Apoptosis in human embryo development: 1. Cerebral cortex. J Cell Mol Med (2002) 0.77
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. J Neurol Sci (2011) 0.76
Therapy of neurodegenerative diseases using neurotrophic factors: cell biological perspective. Expert Rev Neurother (2002) 0.76
Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy. Mov Disord (2007) 0.76
Correlation between the immunophenotypical presentation of dendritic cells and the clinical response to anti-rheumatic treatment in rheumatoid arthritis. Rom J Intern Med (2003) 0.76
Cell fate analysis of embryonic ventral mesencephalic grafts in the 6-OHDA model of Parkinson's disease. PLoS One (2012) 0.75
Alternative generation of CNS neural stem cells and PNS derivatives from neural crest-derived peripheral stem cells. Stem Cells (2015) 0.75
Rapid adaptation to internal states as a coding strategy in visual cortex? Neuroreport (2002) 0.75
[Dementia with Lewy Bodies and its differentiation from Alzheimer's disease]. Neuropsychiatr (2007) 0.75